LXRX vs PTC · rev $21.8M vs P/E 48, rev $2.74B
Lexicon Pharmaceuticals Inc (LXRX) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
LXRX currently screens at market cap $327.2M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the LXRX and PTC stock pages for the full models.
Not investment advice.